株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

固形腫瘍の細胞分離・特性評価:世界市場の予測 (〜2023年)

Cell Separation and Characterization in Solid Tumors: Global Markets Through 2023

発行 BCC Research 商品コード 757053
出版日 ページ情報 英文 181 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.75円で換算しております。
Back to Top
固形腫瘍の細胞分離・特性評価:世界市場の予測 (〜2023年) Cell Separation and Characterization in Solid Tumors: Global Markets Through 2023
出版日: 2018年12月07日 ページ情報: 英文 181 Pages
概要

世界の固形腫瘍の細胞分離・特性評価の市場は予測期間中12.5%のCAGR (年間複合成長率) で推移し、2018年の18億ドルから、2023年には33億ドルの規模に成長すると予測されています。

当レポートでは、世界の固形腫瘍の細胞分離・特性評価の市場を調査し、市場の定義と概要、市場成長への各種影響因子および市場機会の分析、製品タイプ・用途・適応症・手法・地域別の動向と市場規模の推移と予測、特許および技術開発の動向、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場概要

  • 市場動向
  • アジア太平洋:新興市場
  • 市場成長推進因子
  • 市場機会
  • 制約・課題

第4章 市場分析・予測:製品別

  • 固形腫瘍キット
  • マルチマーカー固形腫瘍パネル
  • 試薬
  • その他 (マイクロチップ・マイクロビーズ)

第5章 市場分析・予測:エンドユーズ別

  • 学術機関
  • ラボ・病理
  • 企業
    • バイオテクノロジー
    • 医薬品
    • CRO

第6章 市場分析・予測:適応症別

  • 非悪性腫瘍
  • 前立腺癌
  • 大腸癌
  • 卵巣癌
  • 口腔癌
  • 肺癌
  • その他
    • リンパ腫
    • 甲状腺癌

第7章 市場分析・予測:手法別

  • バイオマーカー
  • DNAエフラックス分析
  • 色素排除アッセイ
  • その他 (生検)

第8章 市場分析・予測:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第9章 :特許レビュー・新規開発

  • 新技術
  • 新製品の開発
  • 特許分析

第10章 市場機会の分析

  • 主要サプライヤーおよび製造業者の位置付け・戦略
    • AdipoGen Life Sciences
    • Cayman Chemical
    • NSJ Bioreagents
    • AAT Bioquest
    • Medical & Biological Laboratories Co., Ltd.
    • Manufacturer Positioning
    • Pfizer Corp.
    • Thermo Fisher Scientific
    • AstraZeneca
    • 第一三共
  • 近年の取り組み
  • R&D
    • AbbVie, Inc.
    • Fluxion Biosciences
    • Genmab A/S
    • Onconova Therapeutics

第11章 企業プロファイル

  • ABBVIE, INC.
  • ABCODIA LTD.
  • ASTRAZENECA
  • BECKMAN COULTER
  • BIO-TECHNE CORP.
  • CELL BIOLABS, INC.
  • CYNVENIO BIOSYSTEMS, INC.
  • 第一三共
  • エーザイ
  • EPIZYME, INC.
  • FLUXION BIOSCIENCES, INC.
  • GENMAB A/S
  • GILEAD SCIENCES, INC.
  • GLAXOSMITHKLINE PLC
  • F. HOFFMAN-LA ROCHE LTD.
  • ILLUMINA, INC.
  • JANSSEN
  • JUNO THERAPEUTICS, INC.
  • LIDDS
  • MERCK
  • MILTENYI BIOTECH
  • MP BIOMEDICALS
  • NEOGENOMICS
  • NOVOCURE
  • ONCOMED PHARMACEUTICALS, INC.
  • ONCONOVA THERAPEUTICS
  • PERKINELMER, INC.
  • PFIZER, INC.
  • PROPANC BIOPHARMA, INC.
  • PSIOXUS THERAPEUTICS LTD.
  • REGNIX
  • SERACARE LIFESCIENCES
  • 大鵬薬品工業
  • 武田薬品工業
  • TARVEDA THERAPEUTICS
  • TESARO, INC.
  • THERMO FISHER SCIENTIFIC
図表

List of Tables

  • Summary Table: Global Market for Cell Separation and Characterization in Solid Tumors, by Product Type, Through 2023
    • Table 1: Use of Immunohistochemistry for Cancer Biomarker Assessment
    • Table 2: Application of FISH for the Study of Solid Tumors
    • Table 3: Manufacturers of Available PCR Instruments
    • Table 4: MACS Products, by Miltenyi Biotec, 2018
    • Table 5: Density Gradient Media Types and Their Principal Uses
    • Table 6: Selection Table
    • Table 7: Types of ATPS with Representative Examples
    • Table 8: Applicable Force Field and Corresponding FFF Techniques
    • Table 9: Microfluidic Methods for Cell Isolation
    • Table 10: Technologies Driving the Future of the Cancer Diagnostic Market
    • Table 11: Global Cancer Incidences, 2005 vs. 2015
    • Table 12: Number of MRI Machines, by Country, 2010 vs. 2015
    • Table 13: Number of CT Scanners, by Country, 2010 vs. 2015
    • Table 14: Number of Mammography Machines, by Country, 2010 vs. 2015
    • Table 15: List of Awareness Day Related to Cancer
    • Table 16: Biomarkers for Different Types of Cancer
    • Table 17: Cost of Prostate Cancer Treatment in India and the U.S., 2017
    • Table 18: Global Market for Cell Separation and Characterization in Solid Tumors, by Product Type, Through 2023
    • Table 19: Global Market for Solid Tumor Kits, by Region, Through 2023
    • Table 20: Thermo Fisher Scientific Solid Tumor Kit
    • Table 21: PerkinElmer Oncology and Solid Tumor Kit Specification
    • Table 22: Global Market for Multi-Marker Solid Tumor Panels, by Region, Through 2023
    • Table 23: Commercially Available Multi-Marker Solid Tumor Panels Using NGS
    • Table 24: Global Market for Reagents, by Region, Through 2023
    • Table 25: MLPA Solutions for Solid Tumors
    • Table 26: Global Market for Other Products, by Region, Through 2023
    • Table 27: Microbeads Offered, by Miltenyi Biotec
    • Table 28: Global Market for Cell Separation and Characterization in Solid Tumors, by End Use, Through 2023
    • Table 29: Global Market for Academics, by Region, Through 2023
    • Table 30: Major Research Institutes and the Solid Tumor Treatment Offered
    • Table 31: Global Market for Labs and Pathology, by Region, Through 2023
    • Table 32: Commonly Used Molecular Diagnostic Techniques
    • Table 33: Global Market for Companies, by Region, Through 2023
    • Table 34: Major Companies and their Product Portfolio
    • Table 35: Global Market for Cell Separation and Characterization in Solid Tumors, by Indication, Through 2023
    • Table 36: Global Market for Non-Cancerous Tumor, by Region, Through 2023
    • Table 37: Global Market for Prostate Cancer, by Region, Through 2023
    • Table 38: Global Market for Colorectal Cancer, by Region, Through 2023
    • Table 39: Colorectal Cancer Biomarkers
    • Table 40: Global Market for Ovarian Cancer, by Region, Through 2023
    • Table 41: Ovarian Carcinoma-Specific Over-Expressed Markers
    • Table 42: Global Market for Breast Cancer, by Region, Through 2023
    • Table 43: List of Biosimilars for Breast Cancer in Phase III Trials
    • Table 44: Global Market for Oral Cancer, by Region, Through 2023
    • Table 45: Global Market for Lung Cancer, by Region, Through 2023
    • Table 46: Clinically Relevant Biomarkers for Lung Cancer
    • Table 47: Global Market for Other Indications, by Region, Through 2023
    • Table 48: Global Market for Cell Separation and Characterization in Solid Tumor, by Method, Through 2023
    • Table 49: Global Market for Biomarkers, by Region, Through 2023
    • Table 50: Global Market for Efflux Analysis of DNA, by Region, Through 2023
    • Table 51: Global Market for Dye Exclusion Assays, by Region, Through 2023
    • Table 52: Global Market for Other Methods, by Region, Through 2023
    • Table 53: North American Market for Cell Separation and Characterization in Solid Tumor, by Product Type, Through, 2023
    • Table 54: North American Market for Cell Separation and Characterization in Solid Tumor, by End Use, Through 2023
    • Table 55: North American Market for Cell Separation and Characterization in Solid Tumor, by Indication, Through 2023
    • Table 56: North American Market for Cell Separation and Characterization in Solid Tumor, by Method, Through, 2023
    • Table 57: North American Market for Cell Separation and Characterization in Solid Tumor, by Country, Through 2023
    • Table 58: The U.S. Expenditures in Medical and Healthcare Research, 2013-2015
    • Table 59: Estimated New Cases and Fatalities of Cancer in the U.S., 2017
    • Table 60: Distribution of Projected New Cancer Cases in Canada, by Cancer Type, 2017
    • Table 61: Canadian Market for Investments Made in Cancer Research, by Organization, 2015
    • Table 62: European Market for Cell Separation and Characterization in Solid Tumor, by Product Type, Through 2023
    • Table 63: European Market for Cell Separation and Characterization in Solid Tumor, by End Use, Through 2023
    • Table 64: European Market for Cell Separation and Characterization in Solid Tumor, by Indication, Through 2023
    • Table 65: European Market for Cell Separation and Characterization in Solid Tumor, by Method, Through 2023
    • Table 66: European Market for Cell Separation and Characterization in Solid Tumor, by Country, Through 2023
    • Table 67: Twenty Most Common Cancer Diseases in the U.K., 2015
    • Table 68: Major Cancer Organizations in Germany
    • Table 69: Asia-Pacific Market for Cell Separation and Characterization in Solid Tumor, by Product Type, Through 2023
    • Table 70: Asia-Pacific Market for Cell Separation and Characterization in Solid Tumor, by End Use, Through 2023
    • Table 71: Asia-Pacific Market for Cell Separation and Characterization in Solid Tumor, by Indication, Through 2023
    • Table 72: Asia-Pacific Market for Cell Separation and Characterization in Solid Tumor, by Method, Through 2023
    • Table 73: Asia-Pacific Market for Cell Separation and Characterization in Solid Tumor, by Country, Through 2023
    • Table 74: Common Cancer Incidences in India, 2015
    • Table 75: Regional Cancer Centers in India
    • Table 76: Rest of World Market for Cell Separation and Characterization in Solid Tumor, by Product Type, Through 2023
    • Table 77: Rest of World Market for Cell Separation and Characterization in Solid Tumor, by End Use, Through 2023
    • Table 78: Rest of World Market for Cell Separation and Characterization in Solid Tumor, by Indication, Through 2023
    • Table 79: Rest of World Market for Cell Separation and Characterization in Solid Tumor, by Method, Through 2023
    • Table 80: Rest-of-World Market for Cell-Separation and Characterization in Solid Tumor, by Country, Through 2023
    • Table 81: Community Health Grant in Latin America
    • Table 82: Estimated Brazilian Cancer Incidences, by Gender, 2016
    • Table 83: Research Institutes in Middle East
    • Table 84: Research Institutes in Africa
    • Table 85: Some of the Urinary and Serological Proteomic Biomarkers Discovered in Prostate Cancer in a South African Cohort
    • Table 86: Comparison of All Cell Isolation Technologies
    • Table 87: Patent Analysis in Selected Countries for Global Cell Separation and Characterization in the Solid Tumor Market, by Category
    • Table 88: Number of Patents in Global Cell Separation and Characterization in the Solid Tumor Market, by Key Players, Jan. 2016-May 2018
    • Table 89: Patents Granted in Global Cell Separation and Characterization in Solid Tumor Market, Jan. 2016-May 2018

List of Figures

  • Summary Figure: Global Market for Cell Separation and Characterization in Solid Tumors, by Product Type, 2017-2023
    • Figure 1: Immunohistochemistry-Staining Method
    • Figure 2: Cell Sorting Machine
    • Figure 3: Common Diagnostic Tests Used for Cancer Diagnostic
    • Figure 4: Global Market Share of Personalized Medicine Under Development, 2016
    • Figure 5: Global Market Share of Oncology Personalized Medicine, 2016
    • Figure 6: Global Cancer Moon-Shot Budget Allocation, 2017-2023
    • Figure 7: UK Cancer Research Funding of Major Cancers, by Type, 2016-2017
    • Figure 8: APAC Countries Cancer Demographics, 2016
    • Figure 9: Biomarkers Used for Cell Separation and Characterization in Solid Tumors
    • Figure 10: North American Market Share in Healthcare Expenditure, by Country, 2016
    • Figure 11: Canadian Cancer Facts, 2017
    • Figure 12: Canadian Market Share for Investments Made for Cancer Research, by Organization Type, 2015
    • Figure 13: Cancer Mortalities in the U.K., 2011-2017
    • Figure 14: Cancer Mortalities in Germany, 2011-2017
    • Figure 15: Prevalence of Breast Cancer in Germany, 2018
    • Figure 16: Cancer Mortalities in France, 2011-2017
    • Figure 17: Spanish Population Share, by Age Structure, 2017
    • Figure 18: Cancer Mortalities in Spain, 2011-2017
    • Figure 19: Cancer Mortalities in Italy, 2011-2017
    • Figure 20: Rest of the European Countries with High Cancer Mortalities, 2014
    • Figure 21: Chinese Expenditure in Healthcare Research, 2016
    • Figure 22: Cancer Mortalities in Japan, 2010-2014
    • Figure 23: Population Aged 65 and Above in Japan, 2013-2016
    • Figure 24: Conventional Solid Tumor Isolation Techniques
    • Figure 25: Product Developments During, 2017-2018
目次
Product Code: BIO167A

Report Highlights:

The global market for cell separation and characterization in solid tumors should grow from $1.8 billion in 2018 to reach $3.3 billion by 2023 at a compound annual growth rate (CAGR) of 12.5% for the period of 2018-2023.

Reagents segment of cell separation and characterization in solid tumors market should grow from $659 million in 2018 to reach $1.2 billion by 2023 at a CAGR of 12.8% for the period of 2018-2023.

Solid tumor kits segment of cell separation and characterization in solid tumors market should grow from $568 million in 2018 to reach $1.0 billion by 2023 at a CAGR of 12.9% for the period of 2018-2023.

Report Scope:

This report consists of the overall analysis of the market landscape. It provides in-depth analysis on market size, growth opportunity in market and product types. The report will serve as a source for 360-degree analysis of the market, thoroughly integrating different models. The solid tumor products in clinical trials and current products available on the market have been studied thoroughly. The report also consists of a detailed overview of all the cell separation technologies and techniques. In addition, the cancer diagnostics market chapter has been provided in detail to give the overall insights in the development of cancer diagnosis technologies. R&D budget of organizations and companies in oncology research have been analyzed in detail. Different approaches have been worked on to derive the market value and market growth rate. Facts and data related to the market from different geographic areas provide a better regional outlook in the report. In the report, country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. This report will help the companies and organizations have an all-around analysis of the cell separation and characterization in the solid tumor market and the most preferred markets regionally.

Report Includes:

  • 54 data tables and 36 additional tables
  • An overview of the global markets and technologies for cell separation and characterization in solid tumors
  • Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Overview of the main markers used for isolation, identification and purification for solid tumors, including surface cell-adhesion molecules such as CD133, CD24, hyaluronic acid (HA) receptor CD44, cytoprotective enzymes such as aldehyde dehydrogenase, ALDH, and transcription factors OCT-4, SOX-2
  • Discussion of the various cell separation technique and technologies such as fluorescence-activated cell sorting (FACS), magnet-activated cell sorting (MACS), density gradient centrifugation, dielectrophoretic (DEP), aqueous two-phase system, field flow fractionation (FFF) and microfluidic platforms
  • Coverage of the major products of the industry such as solid tumor kits, multi-marker solid tumor panels, reagents and microchips and micro-beads
  • Comprehensive analysis of the major companies active in the market, including Abbvie, Inc., AstraZeneca, Beckman Coulter, Daiichi Sankyo and Pfizer, Inc.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Description of Market Trends
    • Asia-Pacific is an Emerging Market
    • Market Drivers
    • Opportunities
    • Limitations and Challenges

Chapter 4: Market Breakdown by Product

  • Solid Tumor Kits
  • Multi-Marker Solid Tumor Panels
  • Reagents
  • Others (Microchips, Micro-Beads)

Chapter 5: Market Breakdown by End Use

  • Academics
  • Labs and Pathologies
  • Companies (Biotechnology, Pharmaceutical and Contract Research Organization (CRO))

Chapter 6: Market Breakdown by Indication

  • Non-Cancerous Tumor
  • Prostate Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Breast Cancer
  • Oral Cancer
  • Lung Cancer
  • Other Indications
    • Lymphoma
    • Thyroid Cancer

Chapter 7: Market Breakdown by Method

  • Biomarkers
  • Efflux Analysis of DNA
  • Dye Exclusion Assays
  • Others (Biopsy)

Chapter 8: Market Breakdown by Region

  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Rest of the World (RoW)
    • Latin America
    • Middle East and Africa (MEA)

Chapter 9: Patent Review/New Developments

  • New Technologies for Cell Characterization and Isolation of Tumor Cells
    • Evolution of Microfluidic Chips
    • Laser Capture Microdissection
    • Evolution of Nano-Velcro Cell-Affinity Assays
    • Second-Generation Nano-Velcro-LMD Technology for Single-Tumor cell Isolation
    • Micromanipulator
    • Limiting Dilution
  • New Product Developments
  • Patent Analysis

Chapter 10: Analysis of Market Opportunities

  • Key Suppliers and Manufacturers Positioning and Strategies
    • AdipoGen Life Sciences
    • Cayman Chemical
    • NSJ Bioreagents
    • AAT Bioquest
    • Medical & Biological Laboratories Co., Ltd.
    • Medical & Biological Laboratories Co., Ltd.
    • Manufacturer Positioning
    • Pfizer Corp.
    • Thermo Fisher Scientific
    • AstraZeneca
    • Daiichi Sankyo
  • Recent Activities
  • R&D Activities
    • AbbVie, Inc.
    • Fluxion Biosciences
    • Genmab A/S
    • Onconova Therapeutics

Chapter 11: Company Profiles

  • ABBVIE, INC.
  • ABCODIA LTD.
  • ASTRAZENECA
  • BECKMAN COULTER
  • BIO-TECHNE CORP.
  • CELL BIOLABS, INC.
  • CYNVENIO BIOSYSTEMS, INC.
  • DAIICHI SANKYO
  • EISAI CO. LTD.
  • EPIZYME, INC.
  • FLUXION BIOSCIENCES, INC.
  • GENMAB A/S
  • GILEAD SCIENCES, INC.
  • GLAXOSMITHKLINE PLC
  • F. HOFFMAN-LA ROCHE LTD.
  • ILLUMINA, INC.
  • JANSSEN
  • JUNO THERAPEUTICS, INC.
  • LIDDS
  • MERCK
  • MILTENYI BIOTECH
  • MP BIOMEDICALS
  • NEOGENOMICS
  • NOVOCURE
  • ONCOMED PHARMACEUTICALS, INC.
  • ONCONOVA THERAPEUTICS
  • PERKINELMER, INC.
  • PFIZER, INC.
  • PROPANC BIOPHARMA, INC.
  • PSIOXUS THERAPEUTICS LTD.
  • REGNIX
  • SERACARE LIFESCIENCES
  • TAIHO PHARMA
  • TAKEDA PHARMACEUTICAL CO., LTD.
  • TARVEDA THERAPEUTICS
  • TESARO, INC.
  • THERMO FISHER SCIENTIFIC
Back to Top